The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
rituximab
A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | C2B8 Monoclonal Antibody CT-P10 IDEC-C2B8 monoclonal antibody | |
| |||
| US brand name: | | Rituxan | |
| |||
| Foreign brand name: | | Mabthera | |
| |||
| Abbreviation: | | MOAB IDEC-C2B8 | |
| |||
| Code names: | | IDEC-102 IDEC-C2B8 | |
| |||
